| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |